muramylnac-ala-isogln-lys-tripeptide and EHS Tumor

muramylnac-ala-isogln-lys-tripeptide has been researched along with EHS Tumor in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Jarowenko, DG; Pellis, NR; Sigler, SC	1

Other Studies

1 other study(ies) available for muramylnac-ala-isogln-lys-tripeptide and EHS Tumor

Article	Year
Muramyl tripeptide: an effective immunotherapy in the surgical setting for pediatric abdominal neoplasms. Journal of pediatric surgery, 1987, Volume: 22, Issue:6 Topics: Abdominal Neoplasms; Acetylmuramyl-Alanyl-Isoglutamine; Animals; Female; Fibrosarcoma; Immunity, Cellular; Immunotherapy; Liposomes; Macrophage Activation; Mice; Mice, Inbred C3H; Micelles; Neoplasm Seeding; Peritoneal Neoplasms; Sarcoma, Experimental; Time Factors	1987

Article

Year

Muramyl tripeptide: an effective immunotherapy in the surgical setting for pediatric abdominal neoplasms.

Journal of pediatric surgery, 1987, Volume: 22, Issue:6

Topics: Abdominal Neoplasms; Acetylmuramyl-Alanyl-Isoglutamine; Animals; Female; Fibrosarcoma; Immunity, Cellular; Immunotherapy; Liposomes; Macrophage Activation; Mice; Mice, Inbred C3H; Micelles; Neoplasm Seeding; Peritoneal Neoplasms; Sarcoma, Experimental; Time Factors

1987